Abstract
Northern hybridization analyses of the oestrogen-inducible mRNAs pLIV1 and pS2 were compared with oestrogen receptor (ER) immunocytochemistry assessments in 40 untreated primary or early recurrent breast tumours. Significant associations were observed between pLIV1/ER (P < 0.03), pS2/ER (P < 0.001) and pLIV1/pS2 (P < 0.04) status. After disease recurrence, patients were treated with assessable courses of endocrine therapies. Positive pLIV1, pS2 and ER statuses in primary disease were consequently found to be predictive of endocrine responsiveness in the secondary lesions (P < 0.03, P < 0.02, P < 0.005 respectively). However, despite these associations, a number of pLIV1- and/or pS2-positive tumours failed to respond to therapy.
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
McClelland, R., Manning, D., Gee, J. et al. Oestrogen-regulated genes in breast cancer: association of pLIV1 with response to endocrine therapy. Br J Cancer 77, 1653–1656 (1998). https://doi.org/10.1038/bjc.1998.271
Issue Date:
DOI: https://doi.org/10.1038/bjc.1998.271
- Springer Nature Limited
This article is cited by
-
Biochemical Markers of Zinc Nutrition
Biological Trace Element Research (2024)
-
Oestrogen-regulated protein SLC39A6: a biomarker of good prognosis in luminal breast cancer
Breast Cancer Research and Treatment (2021)
-
Concordant correlation of LIV-1 and E-cadherin expression in human breast cancer cell MCF-7
Molecular Biology Reports (2009)